BIO.B

Bio Rad Laboratories Stock Price

466.50
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
466.50
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Bio Rad Laboratories Inc BIO.B NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 466.50 0.00 0.00 0.00 466.50 20:00:00
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 466.50 USD

Bio Rad Laboratories Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 13.83B 29.65M 232.34k $ 2.31B $ 1.31B 58.22 8.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
1.00 $ - 0.00% 1.00 17.60%

more financials information »

Bio Rad Laboratories News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIO.B Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week457.70474.00457.70460.87648.801.92%
1 Month453.40474.00429.35452.634413.102.89%
3 Months409.53492.70409.53446.3414056.9713.91%
6 Months378.565492.70320.02397.9521487.9423.23%
1 Year311.52492.70307.28375.35312154.9849.75%
3 Years225.30492.70210.7108319.64319241.20107.06%
5 Years150.13492.70124.50270.85252316.37210.73%

Bio Rad Laboratories Description

Bio-Rad Laboratories Inc manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: life science and clinical diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The clinical diagnostics segment generates over half of the firm's revenue and creates tests systems, informatics systems, test kits, and specialized quality controls for diagnostic labs. It also sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States and Europe.


Your Recent History
NYSE
BIO.B
Bio Rad La..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.